Cite
HARVARD Citation
Celenza, G. et al. (2018). Phenylboronic Acid Derivatives as Validated Leads Active in Clinical Strains Overexpressing KPC‐2: A Step against Bacterial Resistance. ChemMedChem. pp. 713-724. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Celenza, G. et al. (2018). Phenylboronic Acid Derivatives as Validated Leads Active in Clinical Strains Overexpressing KPC‐2: A Step against Bacterial Resistance. ChemMedChem. pp. 713-724. [Online].